Gwynfor Owen Humphreys
Geen lopende functies
Profiel
Gwynfor Owen Humphreys was the founder of Nektar Therapeutics UK Ltd.
which was founded in 1995, where he held the title of Managing Director from 1995 to 2001.
He also held former positions as Chief Executive Officer at Gunsynd Plc from 2004 to 2014, Non-Executive Director at Avacta Group Plc from 2010 to 2015, and Director at SolAeroMed, Inc.
Eerdere bekende functies van Gwynfor Owen Humphreys
| Bedrijven | Functie | Einde |
|---|---|---|
| AVACTA GROUP PLC | Voorzitter | 24-01-2014 |
| GUNSYND PLC | Algemeen Directeur | 15-09-2014 |
Nektar Therapeutics UK Ltd.
 Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Oprichter | 01-01-2001 |
SolAeroMed, Inc.
 SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AVACTA GROUP PLC | Commercial Services |
| GUNSYND PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Nektar Therapeutics UK Ltd.
Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Health Technology |
SolAeroMed, Inc.
SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Health Technology |
